NDC 0056-0173

COUMADIN

Warfarin Sodium

COUMADIN is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Bristol-myers Squibb Pharma Company. The primary component is Warfarin Sodium.

Product ID0056-0173_00803be6-1683-4c09-ad65-6848097b98e4
NDC0056-0173
Product TypeHuman Prescription Drug
Proprietary NameCOUMADIN
Generic NameWarfarin Sodium
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2009-01-01
Marketing CategoryNDA / NDA
Application NumberNDA009218
Labeler NameBristol-Myers Squibb Pharma Company
Substance NameWARFARIN SODIUM
Active Ingredient Strength8 mg/1
Pharm ClassesVitamin K Antagonist [EPC],Vitamin K Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 0056-0173-75

10 BLISTER PACK in 1 CARTON (0056-0173-75) > 10 TABLET in 1 BLISTER PACK (0056-0173-01)
Marketing Start Date2009-01-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0056-0173-01 [00056017301]

COUMADIN TABLET
Marketing CategoryNDA
Application NumberNDA009218
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2009-01-01

NDC 0056-0173-75 [00056017375]

COUMADIN TABLET
Marketing CategoryNDA
Application NumberNDA009218
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2009-01-01

NDC 0056-0173-70 [00056017370]

COUMADIN TABLET
Marketing CategoryNDA
Application NumberNDA009218
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2009-01-01

Drug Details

Active Ingredients

IngredientStrength
WARFARIN SODIUM7.5 mg/1

OpenFDA Data

SPL SET ID:d91934a0-902e-c26c-23ca-d5accc4151b6
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 855340
  • 855320
  • 855326
  • 855346
  • 855332
  • 855298
  • 855288
  • 855344
  • 855318
  • 855324
  • 855334
  • 855302
  • 855314
  • 855290
  • 855338
  • 855296
  • 855312
  • 855304
    • UPC Code
  • 0300560168708
  • 0300560189703
  • 0300560173702
  • 0300560176703
  • 0300560169705
  • 0300560172705
  • 0300560174709
  • 0300560170701

    • Pharmacological Class

    • Vitamin K Antagonist [EPC]
    • Vitamin K Inhibitors [MoA]

    NDC Crossover Matching brand name "COUMADIN" or generic name "Warfarin Sodium"

    NDCBrand NameGeneric Name
    0056-0168COUMADINwarfarin sodium
    0056-0169COUMADINwarfarin sodium
    0056-0170COUMADINwarfarin sodium
    0056-0172COUMADINwarfarin sodium
    0056-0173COUMADINwarfarin sodium
    0056-0174COUMADINwarfarin sodium
    0056-0176COUMADINwarfarin sodium
    0056-0188COUMADINwarfarin sodium
    0056-0189COUMADINwarfarin sodium
    43353-493COUMADINCOUMADIN
    43353-492COUMADINCOUMADIN
    43353-494COUMADINCOUMADIN
    43353-491COUMADINCOUMADIN
    50090-0028COUMADINCOUMADIN
    55154-7701COUMADINCOUMADIN
    55154-7706COUMADINCOUMADIN
    55154-7703COUMADINCOUMADIN
    55154-7704COUMADINCOUMADIN
    55154-7716COUMADINCOUMADIN
    55154-7702COUMADINCOUMADIN
    0093-1712Warfarin SodiumWarfarin Sodium
    0093-1713Warfarin SodiumWarfarin Sodium
    0093-1714Warfarin SodiumWarfarin Sodium
    0093-1715Warfarin SodiumWarfarin Sodium
    0093-1716Warfarin SodiumWarfarin Sodium

    Trademark Results [COUMADIN]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    COUMADIN
    COUMADIN
    71450506 0395328 Live/Registered
    Endo Products, Inc.
    1942-01-27
    © 2025 FDA.report
    This site is not affiliated with or endorsed by the FDA.